Advertisement

Topics

ASCO 2017 – Lung Cancer – Sequencing Treatments for ALK+ Lung Cancer in a Crowded Field – Is there a place for Lorlatinib?

23:00 EDT 9 Aug 2017 | GRACE

Drs. H. Jack West, Matthew Gubens, and Jyoti Patel, gathered post ASCO 2017 to discuss new information regarding lung cancer. In this video, the doctors discuss Sequencing Treatments for ALK+ Lung Cancer in a Crowded Field - Is there a place for Lorlatinib?

Original Article: ASCO 2017 – Lung Cancer – Sequencing Treatments for ALK+ Lung Cancer in a Crowded Field – Is there a place for Lorlatinib?

NEXT ARTICLE

More From BioPortfolio on "ASCO 2017 – Lung Cancer – Sequencing Treatments for ALK+ Lung Cancer in a Crowded Field – Is there a place for Lorlatinib?"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...